HIV Prevention: A World Without AIDS Seems Possible:
An HIV infection is no longer a death sentence. Experts even see a chance to end the pandemic if medications ...
zeit.de/2026/34/hiv-praevention-lenacapavir-spritze-kenia-therapie
Paid articlePaywall
Similar to This
Previous
A new HIV-prevention drug is showing promising signs, but it's difficult to find in Africa and beyond
pbs.org/newshour/health/a-new-hiv-prevention-drug-is-showing-promising-signs-but-its-difficult-to-find-in-africa-and-beyond
OpinionEDITORIAL | Lenacapavir rollout a crucial moment in fight against HIV/AIDS: The phased rollout ensures this intervention will be sustainable and reach those who ...
sundaytimes.timeslive.co.za/opinion-and-analysis/opinion/2026-06-15-editorial-lenacapavir-rollout-a-crucial-moment-in-fight-against-hivaids/
Inside the ‘miracle’ drug rollout that could end Aids: A groundbreaking new drug to prevent HIV infection – the closest the world has to a vaccine – is being ...
independent.co.uk/news/world/africa/hiv-lenacapavir-eswatini-aid-cuts-aids-b2942293.html
The Citizen Apr 08
SA receives first batch of Lenacapavir HIV prevention doses: The six-monthly injectable, is part of the country’s integrated and people-centred HIV prevention ...
citizen.co.za/news/sa-receives-first-batch-lenacapavir-hiv-prevention-doses/
Following the initial trials in Africa of the groundbreaking drug that could put an end to AIDS
english.elpais.com/science-tech/2026-04-04/following-the-initial-trials-in-africa-of-the-groundbreaking-drug-that-could-put-an-end-to-aids.html
‘High uptake of HIV prevention injection will reduce new infection’: Senior medical practitioners have outlined the potential benefits of a newly introduced ...
healthwise.punchng.com/high-uptake-of-hiv-prevention-injection-will-reduce-new-infection/
Nigeria unveils HIV prevention plan, shifts focus beyond treatment: The launch is a response to evolving infection patterns and a move to address gaps in the ...
premiumtimesng.com/health/health-news/866725-nigeria-unveils-hiv-prevention-plan-shifts-focus-beyond-treatment.html
Nigeria receives twice-yearly HIV prevention injection: The development was announced in a statement issued on Wednesday by the National AIDS ...
premiumtimesng.com/news/headlines/863495-nigeria-receives-twice-yearly-hiv-prevention-injection.html
Zimbabwe rolls out long-acting HIV drug, among first countries to do so: Zimbabwe, where HIV has led to tens of thousands of deaths over the past two decades ...
pbs.org/newshour/health/zimbabwe-rolls-out-long-acting-hiv-drug-among-first-countries-to-do-so
A new era in the fight against HIV: On 1 December, recognized globally as World AIDS Day, the World Health Organization (WHO) called on governments and global ...
thedailystar.net/health/healthcare/news/new-era-the-fight-against-hiv-4052166
China pledges $3.5 million for South Africa's HIV response: China has pledged $3.49 million to support HIV prevention services in South Africa over the next two ...
reuters.com/business/healthcare-pharmaceuticals/china-pledges-35-million-south-africas-hiv-response-2025-11-20/
US lists Uganda among 10 countries to benefit from HIV-prevention drug: "Taken only twice a year, lenacapavir offers a highly effective and convenient HIV ...
newvision.co.ug/category/health/us-lists-uganda-among-10-countries-to-benefit-NV_219555
'We can end HIV': Groundbreaking preventative drug to be rolled out for $40 a year from 2027
france24.com/en/health/20250925-groundbreaking-hiv-prevention-injection-to-be-rolled-out-for-40-dollars-a-year-from-2027
Ending the HIV epidemic by 2030: The HIV epidemic has changed beyond recognition. The UK government has made an ambitious pledge to end new HIV transmissions in ...
newstatesman.com/sponsored/2025/09/ending-the-hiv-epidemic-by-2030
In April NPR profiled people who couldn't get their HIV drugs. How are they faring now?
npr.org/sections/goats-and-soda/2025/09/06/g-s1-86617/hiv-positive-aids-zambia
With US aid gone, Cagayan de Oro AIDS support group struggles to survive: (1st UPDATE) The loss of support for Philippine AIDS programs hits the group ...
rappler.com/philippines/mindanao/usaid-gone-cagayan-de-oro-aids-support-group-struggles/
SA gets R520m to buy twice-a-year anti-HIV jab — but there’s a snag: The money is not nearly enough to put two to four million people per year in South Africa on ...
dailymaverick.co.za/article/2025-07-16-sa-gets-r520m-to-buy-twice-a-year-anti-hiv-jab-but-theres-a-snag/
How a new twice-yearly drug is prompting hopes of curbing HIV cases: The FDA has approved a breakthrough preventative treatment for HIV that could change the ...
pbs.org/newshour/show/how-a-new-twice-yearly-drug-is-prompting-hopes-of-curbing-hiv-cases
OpinionThe Drug That Could Revolutionize the Fight Against H.I.V.: Jon Cohen on the new medicine that could save more lives than the Trump cuts to U.S.A.I.D ...
newyorker.com/news/the-lede/the-drug-that-could-revolutionize-the-fight-against-hiv
Experts say a twice-yearly injection that offers 100% protection against HIV is 'stunning'
ajc.com/news/nation-world/experts-say-a-twice-yearly-injection-that-offers-100-protection-against-hiv-is-stunning/KE7K5JBAK5BUFNLLYZE7CEPMUM/
Key FactsAffordable HIV Breakthrough Drug Nears Vaccine Potential
Jul 23, 2024 · Reading time: ~45 sec.
Summary created with AI assistance · Source: theguardian.com
Summary created with AI assistance · Source: theguardian.com
- Lenacapavir, sold as Sunlenca, currently costs $42,250 in the first year but could be produced generically for $40 annually.
- Administered every six months, the drug demonstrated complete protection against HIV in clinical trials involving thousands of women.
- Experts estimate that up to 60 million people might need preventive doses long-term to significantly curb HIV transmission.
- Advocates urge Gilead to license generics broadly in low- and middle-income countries to expand affordable access worldwide.
It’s not an exaggeration to say that meeting the 2030 goal of ending new HIV transmissions hinges on Gilead ensuring people in the global south have fair access to lenacapavir.— Joyce Ouma, senior programmes officer at Y+ Global, on the importance of access to lenacapavir for young people living with or at risk of HIV.
Next